# Should Systematic HSV Serological Screening of Donors Be Implemented to Manage Mismatched HSV D+/R− Liver Transplants?

**Authors:** J. Besombes, V. Thibault, A. Bacle, C. Bressollette-Bodin, C. Camus, B. Giguet, P. Houssel-Debry, C. Pronier

PMC · DOI: 10.3389/ti.2025.14835 · Transplant International · 2025-07-21

## Full-text entities

- **Diseases:** HSV (MESH:D006561), gingivostomatitis (MESH:D013283), viral infections (MESH:D014777), hepatitis (MESH:D056486), infection (MESH:D007239), CMV (MESH:D003586), Infectious Diseases (MESH:D003141)
- **Chemicals:** letermovir (MESH:C000588473), Valganciclovir (MESH:D000077562), SOT (-), Valacyclovir (MESH:D000077483), acyclovir (MESH:D000212)
- **Species:** Human alphaherpesvirus 1 (Herpes simplex virus type 1, no rank) [taxon 10298], Cytomegalovirus (genus) [taxon 10358], Homo sapiens (human, species) [taxon 9606], Human alphaherpesvirus 2 (no rank) [taxon 10310], Hop stunt viroid (no rank) [taxon 12893]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12318879/full.md

## References

12 references — full list in the complete paper: https://tomesphere.com/paper/PMC12318879/full.md

---
Source: https://tomesphere.com/paper/PMC12318879